TAL
CERE

TIG Advisors LLC’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

TIG Advisors LLC’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-588,255
Closed -$24.1M – 74
2024
Q2 		$24.1M Buy
588,255
+565,359
+2,469% +$23.5M 1.73% 18
2024
Q1 		$968K Buy
+22,896
New +$962K 0.09% 42

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

TIG Advisors LLC's CERE Position: Q3 2024 in Review

TIG Advisors LLC sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 588,255 shares — an estimated $24.1M sold.

TIG Advisors LLC first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $24.1M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • TIG Advisors LLC reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • TIG Advisors LLC sold 588,255 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $24.1M.
  • TIG Advisors LLC first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • TIG Advisors LLC's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $24.1M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on TIG Advisors LLC's 13F filing for Q3 2024, filed 14 Nov 2024.